ClinVar Miner

Submissions for variant NM_000154.2(GALK1):c.1083_1096delinsATG (p.Pro362fs)

dbSNP: rs2061563475
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV001246394 SCV001419744 pathogenic Deficiency of galactokinase 2023-02-21 criteria provided, single submitter clinical testing For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the GALK1 protein in which other variant(s) (p.Gln382*) have been determined to be pathogenic (PMID: 10790206). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. This variant has not been reported in the literature in individuals affected with GALK1-related conditions. Information on the frequency of this variant in the gnomAD database is not available, as this variant may be reported differently in the database. This sequence change results in a frameshift in the GALK1 gene (p.Pro362Trpfs*37). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 31 amino acid(s) of the GALK1 protein and extend the protein by 5 additional amino acid residues.
Baylor Genetics RCV001246394 SCV004197946 likely pathogenic Deficiency of galactokinase 2023-02-03 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.